Emerging in the landscape of excess body fat therapy, retatrutide is a unique method. Different from many existing medications, retatrutide works as a twin agonist, concurrently targeting both GLP peptide-1 (GLP-1) and glucose-sensitive insulinotropic substance (GIP) binding sites. The simultaneous engagement fosters several advantageous effects, i